chr11-124250177-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001002905.2(OR8G1):āc.502T>Cā(p.Phe168Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000403 in 1,613,720 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 9/13 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001002905.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR8G1 | NM_001002905.2 | c.502T>C | p.Phe168Leu | missense_variant | 3/3 | ENST00000641972.1 | NP_001002905.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR8G1 | ENST00000641972.1 | c.502T>C | p.Phe168Leu | missense_variant | 3/3 | NM_001002905.2 | ENSP00000493289.1 |
Frequencies
GnomAD3 genomes AF: 0.000368 AC: 56AN: 152166Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000559 AC: 139AN: 248800Hom.: 0 AF XY: 0.000511 AC XY: 69AN XY: 134948
GnomAD4 exome AF: 0.000407 AC: 595AN: 1461554Hom.: 0 Cov.: 59 AF XY: 0.000377 AC XY: 274AN XY: 727044
GnomAD4 genome AF: 0.000368 AC: 56AN: 152166Hom.: 0 Cov.: 32 AF XY: 0.000390 AC XY: 29AN XY: 74338
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 04, 2022 | The c.502T>C (p.F168L) alteration is located in exon 1 (coding exon 1) of the OR8G1 gene. This alteration results from a T to C substitution at nucleotide position 502, causing the phenylalanine (F) at amino acid position 168 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at